Overview
This page focuses on how to think about basic dose and exposure concepts in an abstract way for IGF-DES and similar peptides. It does not provide dosing instructions or protocols.
Key themes in dosing concepts
- Understanding vial amount, dilution volume, and resulting concentration.
- Relating concentration to an abstract "unit" or hypothetical dose.
- Recognizing that pharmacokinetics (absorption, distribution, metabolism, elimination) influence exposure beyond simple vial math.
Context and caveats
Any concrete dosing decisions for IGF-DES must be grounded in product labelling (where it exists), formal clinical guidance, and individualized medical judgment. Educational tools such as calculators and half-life plotters are best treated as aids for understanding, not as dosing engines.
Sport & Anti-Doping Warning
Truncated IGF-1 analogues such as IGF-DES fall under the same peptide hormone/growth factor prohibition as other IGF derivatives, and are frequently cited in discussions of designer growth-factor doping.
From an anti-doping standpoint, IGF-DES is treated similarly to other unapproved IGF analogues regardless of how localized or 'site-specific' its proposed action is.